Biotech Avacta (LON: AVCT) has undertaken AI-driven analysis to assess differences between its pre|CISION peptide drug conjugate platform and a cleavable linker antibody drug conjugate. This showed that the AVA6103 pre|CISION based treatment was more rapid in penetrating the tumour and the tumour selectivity index (ratio of payload in the tumour vs that in plasma) is three times that of the rival treatment. The share price increased 7.08% to
p.overnance, risk and compliance software provider Acuity RM (LON: ACRM) has won a contract with Sopra Steria worth £75,000. The ultimate customer is the British government. This is for a programme that has already generated £250,000 for Acuity RM. This follows a £178,000 contract with the British government. The share price improved 5.88% to 0.9p.
Concierge technology platform provider Ten Lifestyle (LON: TENG) has won a multi-year contract with a financial services provider in the AMEA region. The service will be offered to high net worth and ultra-high net worth clients. This has been won from an incumbent provider, and the transition will start in the second half of the year to August 2026. The share price gained 5.11% to 72p.
One Health Group (LON: OHGR) shares rose 4.29% to 243p following yesterday afternoon’s announcement that planning approval had been obtained for the new surgical hub in Scunthorpe. The facility could be completed within 12 months, and it will cost up to £9m. Some of this has already been spent and there is cash to cover the rest. The surgical hub could generate revenues of £6m-£9m at a potential gross margin of 30% – forecast 2026-27 revenues are £30.7m without a contribution from the surgical hub.
Digital transformation services provider TPXimpact (LON: TPX) has followed up the recent contract wins with a third quarter trading statement that has sparked a forecast rise. Margins continue to improve, so although forecast full year revenues are maintained at £76.2m, the operating profit forecast has been raised from £5.5m to £6.2m. Earnings have been upgraded from 3.4p/share to 3.9p/share. Forecast growth in 2026-27 revenues has been raised from 5% to 10% and operating profit is expected to be £7.5m. The share price is 3.955 higher at 39.5p.
FALLERS
RC Fornax (LON: RCFX) full year figures were in line with previously downgraded estimates. Revenues fell 37% to £4.1m, while the pre-tax loss was £1.4m. The defence contractor says activity has improved since the MoD review. This increases confidence in the 2025-26 forecast revenues of £5.8m and a loss of £2m. In November, cash was raised at 6p/share. The share price slipped 10.5% to 9.625p.
Essensys (LON: ESYS) is recommending a 17p/share cash offer by a bid vehicle backed by founder Mark Furniss that values the flexible workspace software provider at £11.3m. there is a one-for-one share alternative for shareholders that want to retain an interest in the business. The original indicative offer was 20p/share. The share price was already trading below the indicative offer, and it fell a further 9.17% to 16.35p.
Fiinu (LON: BANK) says Conister Bank is delaying the launch of the Plugin Overdraft until the second quarter of 2026. Testing has commenced and a third-party payment interface is being developed for Conister Bank by Fiinu. The share price declined 7.58% to 7.625p.
Alien Metals (LON: UFO) says joint venture partner West Coast Silver reports that assay from the Elizabeth Hill silver project show significant results and extend silver mineralisation away from the historic mine workings both to the north and south. There are multiple near-surface, high-grade silver intersections. The share price dipped 8.11% to 0.17p.